Independent global media advisor MediaSense, has acquired R3, the creative and media advisory for an undisclosed amount, to ...
The reacquisition of the full global commercial rights to ociperlimab and TEVIMBRA in the third quarter of 2023 resulted in ...
Returns represent past performance and do not guarantee future results. Investment return and share price will fluctuate with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback